WHO Approves First Malaria Medication Specifically for Babies in Africa
The WHO has approved a new malaria medication intended specifically for babies in Africa, closing a vital treatment gap and promoting safer care.
The WHO has approved a new malaria medication intended specifically for babies in Africa, closing a vital treatment gap and promoting safer care.
The WHO has approved a new malaria medication intended specifically for babies in Africa, closing a vital treatment gap and promoting safer care.
Women in Germany live longer than men but face unique health challenges as they age, underscoring the need for gender-specific medicine and improved vaccination efforts to reduce cardiovascular risks triggered by infections.